Human Genome Sciences Overview
- Year Founded
-
1992
- Status
-
Acquired/Merged
- Employees
-
1,100
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
- Investments
-
2
Human Genome Sciences General Information
Description
Developer of new pharmaceutical products in genomics. The company is a commercially focused biopharmaceutical company advancing toward the market with three products in late-stage clinical development.
Contact Information
Website
www.hgsi.comCorporate Office
- 14200 Shady Grove Road
- Rockville, MD 20850-7464
- United States
Corporate Office
- 14200 Shady Grove Road
- Rockville, MD 20850-7464
- United States
Human Genome Sciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Human Genome Sciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Human Genome Sciences Patents
Human Genome Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2013066468-A | Human endokine α | Pending | 03-Oct-2012 | ||
| JP-2012044999-A | Neutrokine α | Pending | 04-Nov-2011 | ||
| CA-2847173-A1 | Viral clearance methods | Inactive | 01-Sep-2011 | ||
| EP-2751138-A1 | Viral clearance methods | Inactive | 01-Sep-2011 | ||
| AU-2012301751-A1 | Viral clearance methods | Inactive | 01-Sep-2011 | C07K1/22 |
Human Genome Sciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Human Genome Sciences Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Human Genome Sciences Investments & Acquisitions (2)
Human Genome Sciences’s most recent deal was a Early Stage VC with CoGenesys for . The deal was made on 16-Jun-2006.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CoGenesys | 16-Jun-2006 | Early Stage VC | Biotechnology | ||
| Principia Pharmaceutical | 12-Sep-2000 | Merger/Acquisition | Pharmaceuticals |
Human Genome Sciences Exits (1)
Human Genome Sciences’s most recent exit was on 16-Jun-2006 from CoGenesys. The exit was categorized as with 4 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| CoGenesys | 16-Jun-2006 | Completed |
|
Human Genome Sciences FAQs
-
When was Human Genome Sciences founded?
Human Genome Sciences was founded in 1992.
-
Where is Human Genome Sciences headquartered?
Human Genome Sciences is headquartered in Rockville, MD.
-
What is the size of Human Genome Sciences?
Human Genome Sciences has 1,100 total employees.
-
What industry is Human Genome Sciences in?
Human Genome Sciences’s primary industry is Diagnostic Equipment.
-
Is Human Genome Sciences a private or public company?
Human Genome Sciences is a Private company.
-
What is the current valuation of Human Genome Sciences?
The current valuation of Human Genome Sciences is .
-
What is Human Genome Sciences’s current revenue?
The current revenue for Human Genome Sciences is .
-
Who are Human Genome Sciences’s investors?
, HealthCare Ventures, Oxford Bioscience Partners, and Rho Ventures have invested in Human Genome Sciences.
-
When was Human Genome Sciences acquired?
Human Genome Sciences was acquired on 03-Aug-2012.
-
Who acquired Human Genome Sciences?
Human Genome Sciences was acquired by GSK.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
